Evaluation of COVID-19 Risk in Patients on Systemic Retinoid Therapy

    September 2022 in “ TURKDERM
    Emine Müge Acar, Kemal Özyurt, Rukiye Akyol
    TLDR Systemic retinoids do not increase COVID-19 risk or severity.
    The study evaluated the risk of COVID-19 in 186 patients undergoing systemic retinoid therapy, specifically isotretinoin and acitretin, compared to a control group not on retinoid therapy. Results showed that 1.07% of patients in the retinoid group and 4.3% in the control group were diagnosed with COVID-19, with no cases in patients receiving acitretin. There was no significant difference in COVID-19 incidence or severity between the groups. The study concluded that systemic retinoids did not increase the risk or severity of COVID-19, suggesting they were a safe treatment option during the pandemic.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Off-Label Uses of Retinoids in Dermatology

      research Off-Label Uses of Retinoids in Dermatology

      6 citations , September 2012 in “Our Dermatology Online”
      Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

      research Retinoids in Dermatology

      6 citations , December 1987 in “Mayo Clinic proceedings”
      Retinoids are effective for severe acne and psoriasis but can cause serious side effects and birth defects.
      Retinoids

      research Retinoids

      January 2017 in “Clinical approaches and procedures in cosmetic dermatology”
      Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.